MedTrace Logo

Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer

NCT00831623 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 167

Last updated 2023-03-13

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine hypofractionated conformal proton beam radiation therapy of prostate cancer can achieve similar treatment benefits as our current institutional standard with conventional fractionation.

Conditions

Interventions

RADIATION

Proton Radiation

3 Cobalt Gray Equivalent (CGE) /Day to isocenter, one treatment per day, 5 days per week for 20 treatments (=60 CGE to isocenter/20 fractions)

RADIATION

Proton

As above

Sponsors & Collaborators

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Jerry D Slater, MD · Loma Linda University Medical Center Dept. of Radiation Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-17
Primary Completion
2019-07-18
Completion
2019-07-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00831623 on ClinicalTrials.gov